Code | Display | type |
00.97 |
INTRAVENOUS INFUSION OF MONOCLONAL ANTIBODIES (IGG1) FOR CORONAVIRUS (COVID-19) PATIENT |
procedure |
079.84 |
CORONAVIRUS (COVID-19) INFECTION |
diagnosis |
079.85 |
CORONAVIRUS (COVID-19) INFECTION AFTER RECEIVING ONE VACCINE DOSE |
diagnosis |
079.86 |
CORONAVIRUS (COVID-19) INFECTION AFTER RECEIVING TWO VACCINE DOSES |
diagnosis |
079.87 |
CORONAVIRUS (COVID-19) RECURRENT INFECTION AFTER PREVIOUS EPISODE |
diagnosis |
079.90 |
CORONAVIRUS (COVID-19) INFECTION AFTER RECEIVING THREE VACCINE DOSES |
diagnosis |
079.91 |
CORONAVIRUS (COVID-19) INFECTION AFTER RECEIVING FOUR VACCINE DOSES |
diagnosis |
139.2 |
LATE EFFECTS OF CORONAVIRUS (COVID-19) INFECTION |
diagnosis |
250.76 |
DIABETIC FOOT GANGRENE, ACTIVE |
diagnosis |
250.86 |
DIABETIC FOOT ULCER, ACTIVE |
diagnosis |
539.02 |
PORT LEAK OF GASTRIC BAND PROCEDURE |
diagnosis |
539.03 |
PORT DISPLACEMENT OF GASTRIC BAND PROCEDURE |
diagnosis |
539.04 |
MINOR PORT INFECTION OF GASTRIC BAND PROCEDURE |
diagnosis |
539.05 |
STOMACH OBSTRUCTION BY BAND SLIPPAGE |
diagnosis |
539.06 |
BAND EROSION |
diagnosis |
539.07 |
LATE PORT OR BAND EROSION |
diagnosis |
539.08 |
ESOPHAGEAL DILATATION, ESOPHAGITIS DUE TO GASTRIC BAND |
diagnosis |
539.82 |
LEAKAGE DUE TO OTHER BARIATRIC PROCEDURE |
diagnosis |
539.83 |
HEMORRHAGE DUE TO OTHER BARIATRIC PROCEDURE |
diagnosis |
747.65 |
UTERINE ARTERIOVENOUS MALFORMATION (AVM) |
diagnosis |
796.61 |
NEONATAL OAE SCREEN PASSED |
diagnosis |
796.62 |
NEONATAL OAE SCREEN UNILATERAL FAIL |
diagnosis |
796.63 |
NEONATAL OAE SCREEN BILATERAL FAIL |
diagnosis |
796.64 |
NEONATAL AABR SCREEN PASSED |
diagnosis |
796.65 |
NEONATAL AABR SCREEN UNILATERAL FAIL |
diagnosis |
796.66 |
NEONATAL AABR SCREEN BILATERAL FAIL |
diagnosis |
796.67 |
NEONATAL HEARING SCREEN NOT PERFORMED |
procedure |
995.25 |
ADVERSE EFFECT OF COVID-19 VACCINATION |
diagnosis |
995.95 |
MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH COVID-19 |
diagnosis |
998.84 |
FAILED OR DIFFICULT INTUBATION |
diagnosis |
E829.2 |
POWERED SCOOTER ACCIDENT INJURING PEDESTRIAN |
diagnosis |
E829.3 |
POWERED SCOOTER ACCIDENT INJURING RIDER |
diagnosis |
E949.8 |
COVID-19 VACCINE CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE |
diagnosis |
V01.72 |
CONTACT WITH OR EXPOSURE TO CONFIRMED CORONAVIRUS (COVID-19) |
diagnosis |
V02.55 |
ASYMPTOMATIC PATIENT TESTED POSITIVE FOR CORONAVIRUS (COVID-19) |
diagnosis |
V07.00 |
NEED FOR ISOLATION |
diagnosis |
V07.01 |
PROPHYLACTIC HOME ISOLATION AFTER CONTACT WITH CORONAVIRUS (COVID-19) PATIENT |
diagnosis |
V12.05 |
CORONAVIRUS (COVID-19) RECOVERED PATIENT - CURRENT EPISODE |
diagnosis |
V13.82 |
HISTORY OF CORONAVIRUS (COVID-19) INFECTION |
diagnosis |
V13.83 |
EVIDENCE OF PREVIOUS CORONAVIRUS (COVID-19) INFECTION BY SEROLOGY |
diagnosis |
V13.84 |
STATUS POST CORONAVIRUS (COVID-19) VACCINE, FIRST DOSE |
diagnosis |
V13.85 |
STATUS POST CORONAVIRUS (COVID-19) VACCINE, SECOND DOSE |
diagnosis |
V13.86 |
STATUS POST CORONAVIRUS (COVID-19) VACCINATION TO RECOVERED PATIENT |
diagnosis |
V13.87 |
STATUS POST CORONAVIRUS (COVID-19) VACCINE, THIRD DOSE |
diagnosis |
V13.88 |
STATUS POST CORONAVIRUS (COVID-19) VACCINE,FOURTH DOSE |
diagnosis |
V15.90 |
UNSPECIFIED PERSONAL HISTORY PRESENTING HAZARDS TO HEALTH |
diagnosis |
V15.91 |
HISTORY OF FAILED OR DIFFICULT INTUBATION |
diagnosis |
V15.92 |
HISTORY OF DIABETIC FOOT ULCER |
diagnosis |
V58.60 |
LONG TERM (CURRENT) CANNABIS USE |
diagnosis |
V64.20 |
SURGICAL OR OTHER PROCEDURE NOT CARRIED OUT BECAUSE OF PATIENT'S DECISION |
diagnosis |
V64.21 |
MEDICAL INTERVENTION NOT CARRIED OUT BECAUSE OF CAREGIVER REFUSAL |
diagnosis |
V64.50 |
CORONAVIRUS (COVID-19) TEST NOT CARRIED OUT |
diagnosis |
V65.47 |
CORONAVIRUS COVID-19 VACCINE COUNSELING |
diagnosis |
V71.84 |
OBSERVATION AND EVALUATION FOR SUSPECTED EXPOSURE TO CORONAVIRUS COVID-19 |
diagnosis |
V71.85 |
OBSERVATION AND EVALUATION FOR SUSPECTED ADVERSE EFFECT OF COVID-19 VACCINATION NOT FOUND |
diagnosis |
V72.64 |
CORONAVIRUS (COVID-19) TEST PERFORMED FOR ADMINISTRATIVE PURPOSES |
diagnosis |
V73.70 |
EXAMINATION FOR SUSPECTED CORONAVIRUS (COVID-19) |
diagnosis |
00.98 |
SUBCUTANEOUS INJECTION OF MONOCLONAL ANTIBODIES (IGG1) FOR CORONAVIRUS (COVID-19) PATIENT |
procedure |
11.77 |
AMNIOTIC MEMBRANE GRAFT |
procedure |
13.73 |
INSERTION OF TORIC INTRAOCULAR LENS, UP TO 9 CYLINDER |
procedure |
13.74 |
INSERTION OF TORIC INTRAOCULAR LENS, 9 CYLINDER OR OVER |
procedure |
13.75 |
INSERTION OF MULTIFOCAL INTRAOCULAR LENS |
procedure |
13.76 |
INSERTION OF MULTIFOCAL TORIC INTRAOCULAR LENS |
procedure |
26.33 |
PARTIAL PAROTIDECTOMY |
procedure |
26.34 |
COMPLETE PAROTIDECTOMY |
procedure |
36.08 |
INSERTION OF CORONARY SINUS REDUCER SYSTEM |
procedure |
43.83 |
ENDOSCOPIC (OVERSTITCH) SLEEVE GASTROPLASTY |
procedure |
43.84 |
TRANSORAL ENDOSCOPIC (OVERSTITCH) REVISION OF GASTRIC ANASTOMOSIS |
procedure |
44.33 |
ONE ANASTOMOTIC GASTRIC BYPASS (LAP MINI GASTRIC BYPASS) |
procedure |
44.34 |
OPEN ONE ANASTOMOTIC GASTRIC BYPASS (OPEN MINI GASTRIC BYPASS) |
procedure |
58.7 |
INSERTION OF URETHRAL STENT |
procedure |
75.10 |
DIAGNOSTIC AMNIOCENTESIS |
procedure |
75.11 |
THERAPEUTIC AMNIOCENTESIS |
procedure |
75.39 |
UMBILICAL CORD OCCLUSION FOR FETAL REDUCTION |
procedure |
96.61 |
FECAL MICROBIOTA TRANSPLANT (FMT) BY TRANSANAL ENEMA |
procedure |
96.62 |
FECAL MICROBIOTA TRANSPLANT (FMT) BY ENTERAL INFUSION OF NUTRITIONAL SUBSTANCES |
procedure |
96.63 |
FECAL MICROBIOTA TRANSPLANT (FMT) BY NASO-INTESTINAL TUBE |
procedure |
96.64 |
FECAL MICROBIOTA TRANSPLANT (FMT) BY PEG |
procedure |
96.65 |
FECAL MICROBIOTA TRANSPLANT (FMT) BY COLONOSCOPY |
procedure |
96.66 |
FECAL MICROBIOTA TRANSPLANT (FMT) BY GASTROSCOPY |
procedure |
96.67 |
FECAL MICROBIOTA TRANSPLANT (FMT)- PER OS |
procedure |
99.40 |
CORONAVIRUS (COVID-19) VACCINATION TO RECOVERED PATIENT |
procedure |
99.49 |
CORONAVIRUS COVID-19 VACCINE ADMINISTRATION, FIRST DOSE |
procedure |
99.50 |
CORONAVIRUS COVID-19 VACCINE ADMINISTRATION, SECOND DOSE |
procedure |
99.5A |
CORONAVIRUS COVID-19 VACCINE ADMINISTRATION, THIRD DOSE |
procedure |
99.5B |
CORONAVIRUS COVID-19 VACCINE ADMINISTRATION, FOURTH DOSE |
procedure |